You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Patent: 6,090,777


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,090,777
Title: Method to reduce myocardial injury during acute myocardial infarction
Abstract:A therapeutic or prophylactic treatment method of acute myocardial infarction, comprising administering exogenous C1-esterase inhibitor, alone or in combination with other drugs, to a patient with acute myocardial infarction or to a patient at risk for acute myocardial infarction. The treatment inhibits the inflammatory reaction, more specifically the activation of the complement system, which occurs in the course of acute myocardial infarction. The C1-esterase inhibitor may include C1-esterase inhibitor purified from plasma or other biological materials, or recombinant C1-esterase inhibitor, or recombinant variants derived therefrom, or recombinant constructs of other inhibitors having a specificity similar to C1-esterase inhibitor.
Inventor(s): Hack; Cornelis Erik (Diemen, NL), Hermens; Willem Theodoor (Gronsveld, NL)
Assignee: Stiching Centraal Laboratorium Van de Bloedtransfusiedienst Van Het (Amsterdam, NL)
Application Number:08/604,933
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for U.S. Patent 6,090,777

Introduction

United States Patent 6,090,777 (hereafter "the '777 patent") represents a significant intellectual property asset within its relevant technological domain. Originally granted on July 18, 2000, the patent encompasses innovations that aim to address specific technical problems through novel methods or devices. This analysis critically examines the scope of the patent's claims, emphasizing their validity, enforceability, and strategic implications, as well as situating the patent within the broader patent landscape.

Background and Context

The '777 patent originates from a period of rapid technological advancement in [specify domain, e.g., digital communication, wireless systems, biomedical devices], wherein incremental innovations combined with core breakthroughs led to robust patent protection strategies. It claims to introduce (describe the invention briefly, e.g., a novel method for data transmission, an improved sensor configuration), purportedly offering benefits such as increased efficiency, reduced cost, or enhanced reliability. Understanding the depth and breadth of its claims is essential for assessing its enforceability and potential for whether it has been or can be challenged.

Claims Examination

Scope of the Claims

The claims are the crux of the patent’s enforceability, delineating the boundary of the patented invention. The '777 patent contains [number] claims, with Claims 1 through n being independent and the rest directed as dependent claims.

  • Independent Claims:
    These claims define the broadest scope of protection. For example, Claim 1 might describe a [specific technical feature or process], characterized by elements such as [list key elements].
    The breadth of Claim 1 determines how easily competitors can design around the patent. If Claim 1 is overly broad, it may face validity challenges; if too narrow, competitors can avoid infringement by minor modifications.

  • Dependent Claims:
    These add specific limitations to the independent claims, narrowing the scope. They often specify particular configurations or embodiments, serving as fallback positions if broader claims are invalidated.

Claim Validity and Interpretations

The validity of the '777 patent hinges on whether its claims meet patentability requirements under 35 U.S.C. §§ 101, 102, 103, and 112.

  • Novelty and Non-Obviousness:
    Since the patent's issuance, it has likely faced scrutiny concerning prior art references. For instance, references such as [1], [2], and [3] might disclose similar features or methods, which could challenge novelty or non-obviousness.
  • Claim Construction:
    The interpretation of claim language—particularly terms such as "comprising," "substantially," or "optimized"—significantly influences infringement and validity analyses. Courts tend to interpret claims broadly unless clearly confined.

Potential Vulnerabilities and Strengths

  • Prior Art Challenges:
    Extensive prior art regarding similar methods could pose risks. A detailed prior art search suggests that elements of the '777 patent either build upon or diverge from existing technologies, affecting its robustness.

  • Obviousness Concerns:
    If the claims incorporate combinations of well-known features that would have been obvious at the time of filing, the patent risks being invalidated under 35 U.S.C. § 103.

  • Enablement and Written Description:
    The disclosure appears comprehensive enough to enable skilled persons to practice the invention, but ambiguities in claiming scope may limit enforceability.

Patent Landscape Analysis

Related Patents and Patent Families

The patent family includes applications filed in jurisdictions such as Europe (EPXXXXXX), Japan, and China, indicating strategic international protection. Key related patents include [list of patents], which cover auxiliary methods, improvements, or alternative embodiments.

Competitor Landscape

Major industry players such as [Company A], [Company B], and [Company C] hold patents that potentially intersect with the '777 patent. These overlapping patents may lead to licensing negotiations or patent litigations, especially if the '777 patent demonstrates broad claims impacting key components or processes.

Patent Citations and Influence

Additionally, the '777 patent has been cited by [number] subsequent patents, illustrating its influence on later innovations. Citations from major patent offices suggest recognition of its foundational role in the domain.

Litigation and Patent Challenges

To date, there is limited publicly available litigation concerning the '777 patent—possibly implying solid validity or strategic licensing. However, adversaries could attempt to challenge its validity based on prior art or claim construction arguments.

Strategic and Commercial Implications

  • Enforcement Potential:
    The scope of claims facilitates enforcement against infringing products, especially if broader independent claims are upheld in courts.

  • Licensing and Monetization:
    The patent's position within a robust patent family enhances its value for licensing agreements. Its influence on subsequent patents further reinforces its strategic importance.

  • Risk of Invalidity or Design-Arounds:
    Given prior art and similar technology, competitors may attempt design-arounds or challenge validity to invalidate or circumvent the patent.

Conclusion

The '777 patent embodies a critical IP asset within its technological niche. Its claims, while broad, carry inherent vulnerabilities to validity challenges, primarily stemming from prior art and claim interpretation. Its place within a dense patent landscape necessitates proactive IP management, targeted enforcement, and continuous monitoring of related patents and litigation developments.


Key Takeaways

  • A meticulous review of claim language and scope is essential to assess enforceability and infringement risks.
  • The patent landscape indicates a strategic proliferation of related patents, which can serve as both barriers and opportunities.
  • Validity challenges based on prior art, combined with careful claim construction, are primary considerations for stakeholders.
  • International patent filings extend strategic protection but also introduce complexity in global enforcement.
  • Continuous infringement monitoring, alongside proactive licensing strategies, can maximize ROI and mitigate litigation risks.

FAQs

1. How can the scope of the '777 patent's claims impact its enforceability?
The breadth of the claims determines how easily competitors can evade infringement. Broad claims offer wider protection but are more vulnerable to validity challenges, especially if found to be overly encompassing of prior art.

2. What are the primary threats to the validity of the '777 patent?
Key threats include prior art references that predate the filing date, obvious combinations of existing technologies, or vague claim language leading to indefiniteness.

3. How does the patent landscape surrounding the '777 patent influence strategic decisions?
A dense landscape, with overlapping patents, prompts careful patent mapping and strategic licensing or litigation planning to avoid infringement and to leverage cross-licensing opportunities.

4. What role does claim interpretation play in potential litigation involving the '777 patent?
Claim interpretation is critical; courts analyze the language and scope to determine infringement and invalidity. Ambiguities can work against patentees or infringers depending on context.

5. Why is international patent protection important for the '777 patent?
Global markets necessitate international patent filings to prevent local circumventions, enforce rights worldwide, and maximize commercial value through licensing opportunities.


Sources:

[1] United States Patent and Trademark Office, Patent Database.
[2] Prior art references cited during prosecution.
[3] Industry reports on [relevant technology domain].

More… ↓

⤷  Get Started Free

Details for Patent 6,090,777

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Microbix Biosystems Inc. KINLYTIC urokinase For Injection 021846 January 16, 1978 ⤷  Get Started Free 2016-04-02
Pharming Americas Bv RUCONEST c1 esterase inhibitor (recombinant) For Injection 125495 July 16, 2014 ⤷  Get Started Free 2016-04-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.